198 related articles for article (PubMed ID: 2534970)
21. Reduction of anionic sites in the glomerular basement membrane by heparanase does not lead to proteinuria.
van den Hoven MJ; Wijnhoven TJ; Li JP; Zcharia E; Dijkman HB; Wismans RG; Rops AL; Lensen JF; van den Heuvel LP; van Kuppevelt TH; Vlodavsky I; Berden JH; van der Vlag J
Kidney Int; 2008 Feb; 73(3):278-87. PubMed ID: 18046314
[TBL] [Abstract][Full Text] [Related]
22. Heparan sulfate proteoglycan in the glomerular basement membrane in type 1 diabetes mellitus.
Vernier RL; Steffes MW; Sisson-Ross S; Mauer SM
Kidney Int; 1992 Apr; 41(4):1070-80. PubMed ID: 1513088
[TBL] [Abstract][Full Text] [Related]
23. Early increase of chondroitin sulfate glycosaminoglycan in the glomerular basement membrane of rats with diabetic glomerulopathy.
Karasawa R; Nishi S; Suzuki Y; Imai N; Arakawa M
Nephron; 1997; 76(1):62-71. PubMed ID: 9171302
[TBL] [Abstract][Full Text] [Related]
24. Decreased glomerular basement membrane heparan sulfate proteoglycan in essential hypertension.
Heintz B; Stöcker G; Mrowka C; Rentz U; Melzer H; Stickeler E; Sieberth HG; Greiling H; Haubeck HD
Hypertension; 1995 Mar; 25(3):399-407. PubMed ID: 7875766
[TBL] [Abstract][Full Text] [Related]
25. Sulfated glycosaminoglycan content of glomerular and tubular basement membranes of individuals of different ages.
Reubsaet FA; Veerkamp JH; Monnens LA
Nephron; 1985; 41(4):344-7. PubMed ID: 3934573
[TBL] [Abstract][Full Text] [Related]
26. Noncollagenous matrix components of glomeruli in congenital nephrotic syndrome of the Finnish type: evidence of abnormal splitting of nidogen?
Ljungberg P; Haltia A; Kuusela P; Jalanko H; Holmberg C; Holthöfer H
Exp Nephrol; 1996; 4(5):286-94. PubMed ID: 8931984
[TBL] [Abstract][Full Text] [Related]
27. Hydroxyl radicals depolymerize glomerular heparan sulfate in vitro and in experimental nephrotic syndrome.
Raats CJ; Bakker MA; van den Born J; Berden JH
J Biol Chem; 1997 Oct; 272(42):26734-41. PubMed ID: 9334259
[TBL] [Abstract][Full Text] [Related]
28. Effect of puromycin aminonucleoside on HSPG core protein content of glomerular epithelial cells.
Kasinath BS; Singh AK; Kanwar YS; Lewis EJ
Am J Physiol; 1988 Oct; 255(4 Pt 2):F590-6. PubMed ID: 2972214
[TBL] [Abstract][Full Text] [Related]
29. Adult and paediatric patients with minimal change nephrotic syndrome show no major alterations in glomerular expression of sulphated heparan sulphate domains.
Wijnhoven TJ; Geelen JM; Bakker M; Lensen JF; Rops AL; Kramer AB; Navis G; van den Hoven MJ; van der Vlag J; Berden JH; Wetzels JF; van den Heuvel LP; Monnens LA; van Kuppevelt TH
Nephrol Dial Transplant; 2007 Oct; 22(10):2886-93. PubMed ID: 17526541
[TBL] [Abstract][Full Text] [Related]
30. Glomerular basement membrane antigens in congenital and acquired nephrotic syndrome in childhood.
Huttunen NP; Hallman N; Rapola J
Nephron; 1976; 16(6):401-14. PubMed ID: 1264312
[TBL] [Abstract][Full Text] [Related]
31. Changes in heparan sulfate correlate with increased glomerular permeability.
Groggel GC; Stevenson J; Hovingh P; Linker A; Border WA
Kidney Int; 1988 Feb; 33(2):517-23. PubMed ID: 2452273
[TBL] [Abstract][Full Text] [Related]
32. Is microalbuminuria in diabetes due to changes in glomerular heparan sulphate?
van den Born J; Berden JH
Nephrol Dial Transplant; 1995; 10(8):1277-9. PubMed ID: 8538909
[No Abstract] [Full Text] [Related]
33. Removal of sulfated (heparan sulfate) or nonsulfated (hyaluronic acid) glycosaminoglycans results in increased permeability of the glomerular basement membrane to 125I-bovine serum albumin.
Rosenzweig LJ; Kanwar YS
Lab Invest; 1982 Aug; 47(2):177-84. PubMed ID: 6213815
[No Abstract] [Full Text] [Related]
34. The effect of aminoguanidine on urinary heparan sulphate levels in experimental diabetes.
Unlüçerçi YM; Bekpinar S; Seferoglu G
Acta Diabetol; 2000; 37(2):71-6. PubMed ID: 11194930
[TBL] [Abstract][Full Text] [Related]
35. Polycation binding to glomerular basement membrane. Effect of biochemical modification.
Bertolatus JA; Hunsicker LG
Lab Invest; 1987 Feb; 56(2):170-9. PubMed ID: 3807316
[TBL] [Abstract][Full Text] [Related]
36. Glycosaminoglycan synthesis by glomeruli in vivo and in vitro.
Brown DM; Michael AF; Oegema TR
Biochim Biophys Acta; 1981 Apr; 674(1):96-104. PubMed ID: 6786359
[TBL] [Abstract][Full Text] [Related]
37. Elastase, but not proteinase 3 (PR3), induces proteinuria associated with loss of glomerular basement membrane heparan sulphate after in vivo renal perfusion in rats.
Heeringa P; Van den Born J; Brouwer E; Dolman KM; Klok PA; Huitema MG; Limburg PC; Bakker MA; Berden JH; Daha MR; Kallenberg CG
Clin Exp Immunol; 1996 Aug; 105(2):321-9. PubMed ID: 8706341
[TBL] [Abstract][Full Text] [Related]
38. Increased excretion of urinary glycosaminoglycans in meningococcal septicemia and their relationship to proteinuria.
Oragui EE; Nadel S; Kyd P; Levin M
Crit Care Med; 2000 Aug; 28(8):3002-8. PubMed ID: 10966286
[TBL] [Abstract][Full Text] [Related]
39. Expression of glomerular extracellular matrix components in human diabetic nephropathy: decrease of heparan sulphate in the glomerular basement membrane.
Tamsma JT; van den Born J; Bruijn JA; Assmann KJ; Weening JJ; Berden JH; Wieslander J; Schrama E; Hermans J; Veerkamp JH
Diabetologia; 1994 Mar; 37(3):313-20. PubMed ID: 8174847
[TBL] [Abstract][Full Text] [Related]
40. A specific structural alteration in the heparan sulphate of human glomerular basement membrane in diabetes.
Edge AS; Spiro RG
Diabetologia; 2000 Aug; 43(8):1056-9. PubMed ID: 10990084
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
